Items Tagged with 'SeqWright'


GE Healthcare Buys SeqWright

GE Healthcare Acquisition Announced

On April 4, 2012, GE Healthcare, a unit of General Electric (NYSE: GE) announced that it has acquired SeqWright, Inc., a provider of nucleic acid sequencing and other genomic services.

Read More

Free Report

George Putnam has suceessfully invested in distressed companies for nearly 30 years and The Turnaround Letter's market-beating returns demonstrate the profit potential. He knows all the pitfalls, too--which he shares in this free report!

stock market advice

stock market advice

Distressed Investing Blog

Distressed Investing Blog

The China Syndrome: Stock Market Volatility & Turnaround Investing Strategy, Part II

We believe that it is very important not to let the market volatility spook you into bailing out of stocks or taking other similar drastic action. While it may be painful to ride out a sharp downturn, that is the best strategy. The market will recover from any of these downdrafts, usually quite quickly. Read More.

Your Financial Security is Serious Business...

so why should you trust The Turnaround Letter?

  • Ranked as #1 Performing Newsletter for 15-Yr. Returns: Turnaround Letter's 12.3% vs. S&P's 2.2%
  • 29+ Years of Turnaround Investing Experience & Reliable Stock Market Advice
  • Diverse Monthly Stock Picks Personally Selected by George Putnam

2015 Stock Profit

George Putnam's Turnaround Letter has enjoyed market-beating returns for nearly 30 years now and 2015 is no different: 10 of this year's 12 sale recommendations have seen increases--with four of those 100% or higher. Despite recent stock market turbulence, 2015's closed out stock picks have realized an average gain of 69% thus far.


The chart below reflects The Turnaround Letter's past five sale recommendations.


Most Recent Value Stock Returns


Value Stock Profit